Clinician Resource Library: Partnered CME Offerings
- Key Considerations in Selecting Second-line Therapy for Patients with CLL / SLL (Clinical Care Options: Activity expires 5/14/25)
- Picking Paths in CLL: Individualizing Treatment Across the Disease Spectrum (Clinical Care Options Series: Activity expires 4/1/25)
- From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving Effective Continuous Care (PeerView: Activity expires 2/16/25)
- Toward a Brighter Future for Preventing COVID-19 in Patients with Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation Agents (PeerView: Activity expires 12/31/24)
- Therapy Selection in CLL: Knowing How to Choose in Frontline and R/R Settings (PleXus Communications: Activity expires 11/16/24)
- Taking Direction From Biomarkers and Prognostic Factors in CLL: Interprofessional Strategies for Addressing Challenges with Continuous BTKi Therapy (PeerView: Activity expires 8/1/24)
- Defying the Odds with Innovation in CLL: Perspectives on Personalized Care, Multiagent Platforms, and Sequential Strategies (PeerView: Activity expires 7/2/24)
Clinician Resource Library
AUTOIMMUNE HEMOLYTIC ANEMIA
Autoimmune hemolytic anemia (AIHA) is the most common autoimmune condition associated with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
View and Download the Autoimmune Hemolytic Anemia Resource
SMALL LYMPHOCYTIC LYMPHOMA
Small lymphocytic lymphoma (SLL) is a slow-growing, chronic blood cancer involving an abnormal overgrowth of white blood cells called B-lymphocytes.
View and Download the SLL Resource Document
BIOMARKER TESTING
A one-page summary of what you need to know about the three most important tests that need to be performed to guide your CLL or SLL treatment selection.
View and Download the Test Before Treat One-Pager
IMMUNE THROMBOCYTOPENIC PURPURA
Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
View and Download the Immune Thrombocytopenic Purpura Resource
CANCER-RELATED FATIGUE
Fatigue is one of the most common symptoms experienced by those living with CLL and SLL, and it is also commonly overlooked, underreported, and undertreated.
View and Download the Cancer-Related Fatigue Resource
TUMOR LYSIS SYNDROME
Tumor lysis syndrome is a rare condition that can happen due to the rapid death of cancer cells. When the cancer cells are killed, the debris from inside the cells enters the bloodstream.
View and Download the Tumor Lysis Syndrome Resource
CHRONIC LYMPHOCYTIC LEUKEMIA
Chronic lymphocytic leukemia (CLL) is a slow-growing blood cancer involving the abnormal overgrowth of a type of white blood cell called B-lymphocytes
View and Download the CLL Resource Document
MORE RESOURCES COMING SOON
Visit the Resource Library as we add more educational materials.
